DOCU Stock Recent News
DOCU LATEST HEADLINES
Docusign (DOCU -2.34%) stock was a pandemic darling. Its stock price peaked at around $310 in 2021, a tenfold gain from its 2018 IPO price of $29.
Heading into its second-quarter earnings report for its 2026 fiscal year (FY), DocuSign Inc. NASDAQ: DOCU was showing signs of being a value play in an overvalued technology sector. DOCU stock was up 1.1% since mid-August, and many investors were hoping that its earnings report would be the catalyst the stock needed.
Shares of Docusign (DOCU 4.76%) jumped on Friday, finishing the day up 4.8% after climbing as much as 8.9% earlier in the session. The move came as the S&P 500 (^GSPC -0.32%) dropped 0.3% and the Nasdaq Composite (^IXIC -0.03%) was flat.
DocuSign, Inc. DOCU shares rose Friday after the e-signature giant beat second-quarter expectations.
U.S. equities turned lower at midday following the government's weaker-than-expected August employment report. The Dow Jones Industrial Average, S&P 500, and Nasdaq were down.
Docusign, Inc. (NASDAQ: DOCU) shares gained nearly 7% to $81.23 in late-morning trading on Friday after the digital agreements and eSignatures provider's fiscal 2026 second-quarter financial results surpassed analyst expectations. Docusign reported earnings for the quarter of $0.31 per share on revenue that rose 9% year over year to $800.6 million.
Docusign (DOCU) shares jumped Friday, after the maker of electronic signature software posted strong quarterly results and boosted its outlook as it added more customers and expanded its artificial intelligence offerings.
Allan Thygesen, Docusign CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent quarter, what industries the company is seeing the most adoption in, and much more.
Docusign (DOCU) moved higher after posting and earnings beat and doubling down on A.I. advancements.
DocuSign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company's turnaround is evident in rebounding billings, stabilizing net retention, and expanding free cash flow, supporting a continued buy rating. International growth and broad applicability across industries provide DocuSign with significant long-term upside and independent catalysts for outperformance.